2001
DOI: 10.1182/blood.v97.11.3612
|View full text |Cite
|
Sign up to set email alerts
|

Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki

Abstract: Identification of cytogenetic abnormalities is an important clue for the elucidation of carcinogenesis. However, the cytogenetic and clinical significance of adult T-cell leukemia/lymphoma (ATLL) is still unclear. To address this point, cytogenetic findings in 50 cases of ATLL were correlated with clinical characteristics. Karyotypes showed a high degree of diversity and complexity. Aneuploidy and multiple breaks (at least 6) were observed frequently in acute and lymphoma subtypes of ATLL. Breakpoints tended t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

8
65
1
1

Year Published

2002
2002
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(75 citation statements)
references
References 61 publications
8
65
1
1
Order By: Relevance
“…In contrast, Bcl11b À/À mice exhibit a reduced cellularity and apoptosis of thymocytes (Wakabayashi et al, 2003b), and this apoptotic phenotype seems to contradict the fact that Bcl11b being the tumor suppressor. Genetic changes of these two genes were also found in human hematopoietic malignancies (Sun et al, 1999;Bernard et al, 2001;Itoyama et al, 2001;Yagi et al, 2002;MacLeod et al, 2003;Nagel et al, 2003;Bezrookove and van Zelderen-Bhola, 2004;Przybylski et al, 2005). Studies in other laboratories implicated several genes in the lymphoma development such as Myc, Notch1 and PTEN (Klein, 1979;Graham et al, 1985;Ellisen et al, 1991;Mao et al, 2003;Lin et al, 2006;O'Neil et al, 2006).…”
Section: Introductionmentioning
confidence: 89%
“…In contrast, Bcl11b À/À mice exhibit a reduced cellularity and apoptosis of thymocytes (Wakabayashi et al, 2003b), and this apoptotic phenotype seems to contradict the fact that Bcl11b being the tumor suppressor. Genetic changes of these two genes were also found in human hematopoietic malignancies (Sun et al, 1999;Bernard et al, 2001;Itoyama et al, 2001;Yagi et al, 2002;MacLeod et al, 2003;Nagel et al, 2003;Bezrookove and van Zelderen-Bhola, 2004;Przybylski et al, 2005). Studies in other laboratories implicated several genes in the lymphoma development such as Myc, Notch1 and PTEN (Klein, 1979;Graham et al, 1985;Ellisen et al, 1991;Mao et al, 2003;Lin et al, 2006;O'Neil et al, 2006).…”
Section: Introductionmentioning
confidence: 89%
“…Moreover, the breaks in 14q32 in ATLL seem not to target TCL1. 46 They have been reported to map mostly between TCL1 and the telomeric marker D14S250 although no candidate oncogenes in ATLL have been described so far. 47 A gene located in that region is BCL11B/CTIP2.…”
Section: Discussionmentioning
confidence: 99%
“…23 In contrast, in ATLL the involvement of either IGH or TCL genes was excluded in the majority of cases with 14q32 alterations. 25 To our knowledge, hardly any molecular breakpoint analyses have been performed on T-ALL inv(14)(q11q32) or t(14;14)(q11;q32). 24 The first molecular analysis of inv(14)(q11q32) was performed in the childhood lymphoblastic T-cell lymphoma-derived cell line SUP T1 and demonstrated joining between an immunoglobulin heavy-chain variable gene segment (VH) with a Ja segment from the TCRA/D locus.…”
Section: Discussionmentioning
confidence: 99%